title: A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults.
abstract: Humanin (HN) is a newly identified neuroprotective peptide that specifically suppresses Alzheimer's disease (AD)-related neurotoxicity. HN peptide has been detected in the human AD brain as well as in mouse testis and colon by immunoblot and immunohistochemical analyses. By means of yeast two-hybrid screening, we identified TRIM11 as a novel HN-interacting protein. TRIM11, which is a member of protein family containing a tripartite motif (TRIM), is composed of a RING finger domain, which is a putative E3 ubiquitin ligase, a B-box domain, a coiled-coil domain and a B30.2 domain. Deletion of the B30.2 domain in TRIM11 abolished the interaction with HN, whereas the B30.2 domain alone did not interact with HN. For their interaction, at least the coiled-coil domain was indispensable together with the B30.2 domain. The intracellular level of glutathione S-transferase-fused or EGFP-fused HN peptides or plain HN was drastically reduced by the coexpression of TRIM11. Disruption of the RING finger domain by deleting the first consensus cysteine or proteasome inhibitor treatment significantly diminished the effect of TRIM11 on the intracellular level of HN. These results suggest that TRIM11 plays a role in the regulation of intracellular HN level through ubiquitin-mediated protein degradation pathways.
authors.affiliation: Department of Pharmacology, Keio University School of Medicine, General Research Building, 3rd and 6th Floor, 35 Shinanomachi, Tokyo 160-8582, Japan. niikurat@sc.itc.ac.jp
authors.forename: Takako
authors.initials: T
authors.lastname: Niikura
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: Hirohisa
authors.initials: H
authors.lastname: Tajima
authors.forename: Miho
authors.initials: M
authors.lastname: Ishizaka
authors.forename: Yohichi
authors.initials: Y
authors.lastname: Yamagishi
authors.forename: Masaoki
authors.initials: M
authors.lastname: Kawasumi
authors.forename: Mikiro
authors.initials: M
authors.lastname: Nawa
authors.forename: Kenzo
authors.initials: K
authors.lastname: Terashita
authors.forename: Sadakazu
authors.initials: S
authors.lastname: Aiso
authors.forename: Ikuo
authors.initials: I
authors.lastname: Nishimoto
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000544:Alzheimer Disease / Q000378:metabolism*; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D015151:Immunoblotting; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins / Q000378:metabolism*; D051379:Mice; D018696:Neuroprotective Agents / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D011506:Proteins / Q000378:metabolism*; D020798:Two-Hybrid System Techniques; D025801:Ubiquitin / Q000378:metabolism; D015003:Yeasts
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D018696:Neuroprotective Agents; D011506:Proteins; C114030:TRAT1 protein, human; D025801:Ubiquitin; C427211:humanin